ArticleProteomics2004
Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique.
Article in Proteomics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Calumenin, A Calcium-Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise.FASEB bioAdvances · 2025Review
- Silencing Calumenin Expression via Artificial MicroRNA, a Potential Breakthrough for Inhibiting Proliferation, Halting Migration, and Triggering Apoptosis in Breast Cancer Cells.Advanced pharmaceutical bulletin · 2025Article
- NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.Molecular & cellular proteomics : MCP · 2015Article
- Article
- Differential expression of genes associated with the progression of renal disease in the kidneys of liver-specific glucokinase gene knockout mice.International journal of molecular sciences · 2013Article
- An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.Journal of proteomics · 2012Article
- Global secretome analysis identifies novel mediators of bone metastasis.Cell research · 2012Article
- Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.Cell research · 2012Article
- Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration.PloS one · 2012Article
- A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach.Electrophoresis · 2010Article
- Integrated gene networks in breast cancer development.Functional & integrative genomics · 2010Review
- Gradient chromatofocusing-mass spectrometry: a new technique in protein analysis.Journal of the American Society for Mass Spectrometry · 2008Article
- Breast tumor metastasis: analysis via proteomic profiling.Expert review of proteomics · 2008Review
- Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.Molecular cancer · 2008Article
- Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling.Journal of proteome research · 2007Article
- Comprehensive analysis of proteins of pH fractionated samples using monolithic LC/MS/MS, intact MW measurement and MALDI-QIT-TOF MS.Journal of mass spectrometry : JMS · 2007Article
- Genomic signatures of breast cancer metastasis.Cytogenetic and genome research · 2007Article
- Using size exclusion chromatography-RPLC and RPLC-CIEF as two-dimensional separation strategies for protein profiling.Electrophoresis · 2006Article
- The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.Cancer research · 2005Article
- Application of proteomics in the study of tumor metastasis.Genomics, proteomics & bioinformatics · 2004Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
For most cancer cell types, the acquisition of metastatic ability leads to clinically incurable disease. The identification of molecules whose expression is specifically correlated with the metastatic spread of cancer would facilitate the design of therapeutic interventions to inhibit this lethal process. In order to facilitate metastasis gene discovery we have previously characterized a pair of monoclonal cell lines from the human breast carcinoma cell line MDA-MB-435 that have different metastatic phenotypes in immune-compromised mice. In this study, serum-free conditioned media was collected from the cultured monoclonal cell lines and a mass mapping technique was applied in order to profile a component of each cell line proteome. We utilized chromatofocusing in the first dimension to obtain a high resolution separation based on protein pI, and nonporous silica reverse-phase high performance liquid chromatography was used for the second dimension. Selected proteins were identified on the basis of electrospray ionization time of flight mass spectrometry (ESI-TOF MS) intact protein mapping and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) peptide mass fingerprinting. Using this approach we were able to map over 400 proteins and plot them as a 2-D map of pI versus accurate M(r). This was performed over a pI range of 4.0-6.2, and a mass range of 6-80 kDa. ESI-TOF MS data and further analysis using MALDI-TOF MS confirmed and identified 27 differentially expressed proteins. Proteins associated with the metastatic phenotype included osteopontin and extracellular matrix protein 1, whereas the matrix metalloproteinase-1 and annexin 1 proteins were associated with the non-metastatic phenotype. These findings demonstrate that the mass mapping technique is a powerful tool for the detection and identification of proteins in complex biological samples and which are specifically associated with a cellular phenotype.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.